SCHEMBL9062853

SCHEMBL9062853

CCOC(OCC)P(=O)(O)C[C@H](O)CNC(C)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ CYP2C9 P11712 1/20 0.62
▸ CYP2C19 P33261 1/20 0.62
▸ KMT2A Q03164 1/20 0.62
▸ CYP3A4 P08684 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ ALOX15 P16050 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A4 P31645 2/20 0.37
▸ FFAR1 O14842 2/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8751270 1.00 CYP2D6 (0.62) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL8751267 1.00 CYP2D6 (0.62) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL8751300 1.00 CYP2D6 (0.62) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL8976491 1.00 CYP2D6 (0.62) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL8976321 1.00 CYP2D6 (0.62) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL9062847 1.00 CYP2D6 (0.62) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL8976082 0.91 MEN1 (0.53) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL8976090 0.91 MEN1 (0.53) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL8976085 0.91 MEN1 (0.53) CYP2D6MEN1CYP2C9CYP2C19KMT2A
SCHEMBL9062562 0.88 MEN1 (0.47) CYP2D6MEN1CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463560-B1 New antiepileptic agents CIBA GEIGY AG (CH) 1995-10-25 — — EP claimed
US-5545631-A GAMMA-AMINOBUTYRIC ACID ANTAGONIST; TREATS PETIT-MAL TYPE EPILEPSIES CIBA-GEIGY CORPORATION (US) 1996-08-13 — — US disclosed
US-5229379-A Gamma-aminobutyric acid antagonists CIBA-GEIGY CORPORATION (US) 1993-07-20 — — US disclosed
Send feedback